The transition from today population-based "reactive" medicine to the individual patient-centred data-driven medicine of tomorrow is the big challenge that the health system will face in the next years worldwide. Therefore, in addition to the clinical-pathological parameters, many other factors such as inherited genetics, ethnicity, age and gender, lifestyle including nutrition and, more generally, the socio-economic environment will have to be taken into consideration. Within this frame, the main aim was to collect opinions from international experts in order to identify long term future needs and bottlenecks in the exploitation of Theranostics for a Predictive, Preventive, Personalized and Participatory Medicine (P4-Medicine).
THERANOSTIC FOR P4 MEDICINE
CATERINA CINTI;FRANCESCO BALDINI;DANIELA BANTI;GABRIELLA LEO;LUISA TONDELLI;
2016
Abstract
The transition from today population-based "reactive" medicine to the individual patient-centred data-driven medicine of tomorrow is the big challenge that the health system will face in the next years worldwide. Therefore, in addition to the clinical-pathological parameters, many other factors such as inherited genetics, ethnicity, age and gender, lifestyle including nutrition and, more generally, the socio-economic environment will have to be taken into consideration. Within this frame, the main aim was to collect opinions from international experts in order to identify long term future needs and bottlenecks in the exploitation of Theranostics for a Predictive, Preventive, Personalized and Participatory Medicine (P4-Medicine).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
